Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-28 Purchase |
2020-12-28 4:30 pm |
Cellectar Biosciences Inc. | CLRB | Elefant Dov Chief Financial Officer |
7,407 | $1.35 | $9,999 | 11,755 (Direct) |
View |
| 2020-06-05 Purchase |
2020-06-08 4:08 pm |
Cellectar Biosciences Inc. | CLRB | Elefant Dov Chief Financial Officer |
4,348 | $1.145 | $4,978 | 6,522 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-28 Option Award |
2025-01-30 7:33 pm |
2025-01-28 2035-01-28 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
186,345 | $0 | 186,345 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:43 pm |
N/A 2034-02-01 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
84,000 | $0 | 84,000 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 6:00 pm |
N/A 2033-07-03 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
309,900 | $0 | 309,900 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-01 4:38 pm |
N/A 2032-02-28 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:06 pm |
N/A 2032-01-25 |
Cellectar Biosciences Inc. | CLRB | Elefant Dov Chief Financial Officer |
422,000 | $0 | 422,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-05 5:46 pm |
N/A 2031-03-04 |
Cellectar Biosciences Inc. | CLRB | Elefant Dov Chief Financial Officer |
430,000 | $0 | 430,000 (Direct) |
View |